Neoprobe moves closer to Biosonix purchase

Radiopharmaceutical developer Neoprobe has signed a definitive acquisition agreement to purchase the outstanding shares of Israel-based blood-flow technology vendor Biosonix by the end of the year. Neoprobe of Dublin, OH, will issue 9.7 million shares of its common stock to Biosonix shareholders at closing, with an additional 2.1 million shares to be provided upon the satisfaction of a milestone event involving Biosonix product development, according to Neoprobe.

By AuntMinnie.com staff writers
December 11, 2001

Related Reading

Neoprobe revenue drops in third quarter, November 5, 2001

Biosonix gets CE mark for FlowGuard, October 4, 2001

Neoprobe to buy Biosonix, September 7, 2001

Neoprobe revenues, net income slide, August 8, 2001

CZT supplier highlights small-FOV gamma camera, June 27, 2001

Copyright © 2001 AuntMinnie.com

Page 1 of 3618
Next Page